HIV News and Research

RSS

PEPFAR has helped millions, but 'hard work' lies ahead to sustain gains

PEPFAR, initiated in 2003, is "the largest global health initiative ever undertaken focused on a single disease," a Washington Post editorial writes, noting, "Now, after four years of work, some 400 interviews and visits to 13 nations, the Institute of Medicine of the National Academy of Sciences has provided [an] examination of this incredibly ambitious program."

27 Feb 2013

Examining global efforts against Buruli ulcer

"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.

27 Feb 2013

AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

"A small team of HIV/AIDS activists is trailing Kenyan presidential candidates as they crisscross the country, pressing them to increase their commitment to the care and treatment of people living with HIV," PlusNews reports.

27 Feb 2013

DNDi receives 2013 BBVA Foundation Frontiers of Knowledge and Culture Award

Today in Madrid, Spain, the Drugs for Neglected Diseases initiative (DNDi) received the BBVA Foundation 'Frontiers of Knowledge and Culture Award for Development Cooperation'. This EUR 400,000 award will be presented at a ceremony in Madrid, Spain, in June of this year.

27 Feb 2013

Viewpoints: GOP faces pressure from spending cuts effects on daily life; President needs to lead on Medicare cuts

Cuts this draconian have no place in a tottering economy. But, realistically, the only way to break this standoff is for the cuts to exact their toll on daily life, causing Republicans to face pressure from the public to negotiate an alternative plan with higher revenues in March as part of talks to finance the government for the final six months of the fiscal year.

26 Feb 2013

Govs brace for impact of scheduled cuts in home states

The nation's governors met in Washington over the weekend, and among their hottest topics: a White House warning regarding the state-by-state impact of sequestration, which is scheduled to kick in March 1.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Early lymphoid progenitors thrive in an osteoblastic niche: Study

The Children's Medical Center Research Institute at UT Southwestern has deepened the understanding of the environment within bone marrow that nurtures stem cells, this time identifying the biological setting for specialized blood-forming cells that produce the infection-fighting white blood cells known as T cells and B cells.

25 Feb 2013

Kaposi’s sarcoma risk factors revealed

Scientists have uncovered an intriguing relationship between the risk for Kaposi’s sarcoma, smoking, and the use of highly active antiretroviral therapy.

25 Feb 2013

Two USC scientists develop new algorithm to help predict value of DNA sequencing

Two USC scientists have developed an algorithm that could help make DNA sequencing affordable enough for clinics - and could be useful to researchers of all stripes.

25 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

The epicentre of the HIV pandemic is in sub-Saharan Africa, though prevalence of infection varies dramatically between countries for reasons not completely understood.

25 Feb 2013

World closer than ever to ending pediatric AIDS

Writing in the Huffington Post's "Global Motherhood" blog, Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, highlights the foundation's "first annual 'Global Champions for a Mother's Fight' gala, an opportunity to honor some of our heroes in the battle against pediatric HIV/AIDS and discuss global change, innovation, and advocacy."

24 Feb 2013

UNAIDS launches online platform to highlight relevant research

"UNAIDS has launched an online platform, UNAIDS Science now, which highlights some of those papers that are particularly relevant to the United Nations high level targets," the agency reports in an article on its webpage.

24 Feb 2013

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

"An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research," the Los Angeles Times reports.

23 Feb 2013

Evolution of PEPFAR necessary for continued success

PEPFAR has "met or even surpassed most" of its "bold goals," including "saving the lives of millions of people; supporting the scale-up of HIV prevention, care, and treatment; and strengthening systems and policies for the HIV response," Robert Black of the Johns Hopkins Bloomberg School of Public Health writes in a Lancet opinion piece, noting the release of the Institute of Medicine's (IOM) "Evaluation of PEPFAR" on Wednesday.

22 Feb 2013

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

Over nearly a century, progressives have pressed for a national, single-payer healthcare system. When it comes to health reform, what have conservatives stood for? For far too long, conservatives have failed to coalesce around a long-term vision of what a free-market healthcare system should look like. ... Obamacare is the logical byproduct of this conservative policy neglect.

22 Feb 2013

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.

21 Feb 2013

Proposals, partisan rhetoric fly in countdown to March 1 spending cuts

News outlets report how spending reductions will impact health care programs. Meanwhile, in hopes of creating momentum toward a compromise, Alan Simpson and Erskine Bowles on Tuesday unveiled a $2.4 trillion proposal that includes $600 billion in spending reductions to health-care programs such as Medicare and Medicaid.

21 Feb 2013

Gilead to resolve Viread patent litigation case with Teva

Gilead Sciences, Inc. today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), a treatment for HIV infection and chronic hepatitis B. Under the terms of the settlement, Teva will be allowed to launch a generic version of Viread on December 15, 2017.

20 Feb 2013

HIV News and Research

PEPFAR has helped millions, but 'hard work' lies ahead to sustain gains

Examining global efforts against Buruli ulcer

AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

DNDi receives 2013 BBVA Foundation Frontiers of Knowledge and Culture Award

Viewpoints: GOP faces pressure from spending cuts effects on daily life; President needs to lead on Medicare cuts

Govs brace for impact of scheduled cuts in home states

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Early lymphoid progenitors thrive in an osteoblastic niche: Study

Kaposi’s sarcoma risk factors revealed

Two USC scientists develop new algorithm to help predict value of DNA sequencing

Comprehensive portfolio of antiretroviral products from Mylan

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

World closer than ever to ending pediatric AIDS

UNAIDS launches online platform to highlight relevant research

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

Evolution of PEPFAR necessary for continued success

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

Proposals, partisan rhetoric fly in countdown to March 1 spending cuts

Gilead to resolve Viread patent litigation case with Teva

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News